Eurofins Expands Its Footprint with the Acquisition of Gözlem Group in Turkey
March 16 2017 - 2:30AM
Business Wire
Regulatory News:
Eurofins (Paris:ERF)
Eurofins Scientific (EUFI.PA), the global leader in food
testing, announces the acquisition of G�zlem Gýda Kontrol ve
Araþtýrma Laboratuvarlarý (“G�zlem”), one of the leading food
testing laboratories in Turkey.
Founded in 2002, G�zlem has established itself as one of the
main food testing laboratories in the country, and has strong
relationships in the national food and beverage industry. The
company employs 124 staff, and operates 1 large laboratory in
Istanbul, as well as internal laboratories at 13 client sites in
Istanbul, Ankara and Izmir regions.
The acquisition of G�zlem provides Eurofins with a strong
platform to accelerate the roll-out of its capabilities to serve
the thriving food and beverage industry, which at almost 19% of
GDP, remains a key trading sector1 in Turkey. In return, G�zlem
will be able to leverage Eurofins’ network capabilities and
unequalled tests portfolio to accelerate its market share expansion
and secure market leadership in the fastest-growing regions of
Turkey.
Comment from Dr. Gilles Martin, Eurofins CEO: “The
acquisition of G�zlem is another demonstration of our commitment to
continuously reinforce our market leadership in the EMEA region. We
are looking forward to strengthening G�zlem’s market position by
giving it access to the full range of services and capabilities of
the Eurofins Group.”
For more information, please visit
www.eurofins.com.
Notes for the editor:
Eurofins – a global leader in bio-analysis
Eurofins Scientific through its subsidiaries (hereinafter
sometimes “Eurofins” or “the Group”) believes it is the world
leader in food, environment and pharmaceutical products testing and
that it is also one of the global independent market leaders in
certain testing and laboratory services for agroscience, genomics,
discovery pharmacology and for supporting clinical studies. In
addition, Eurofins is one of the key emerging players in specialty
clinical diagnostic testing in Europe and the USA. With over 27,000
staff in 310 laboratories across 39 countries, Eurofins offers a
portfolio of over 130,000 analytical methods for evaluating the
safety, identity, composition, authenticity, origin and purity of
biological substances and products, as well as for innovative
clinical diagnostic. The Group objective is to provide its
customers with high-quality services, accurate results on time and
expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgment of
Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantee can be made as to their validity.
1
http://www.food-exhibitions.com/Market-Insights/Turkey-and-Eurasia/Archive/The-Turkish-food-industry-trends-opportunities
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170316005101/en/
Investor RelationsEurofins ScientificPhone: +32 2 766
1620E-mail: ir@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024